NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT05109091,Study of ATH434 in Participants with Multiple System Atrophy,https://clinicaltrials.gov/study/NCT05109091,,COMPLETED,This study will assess the safety and efficacy of ATH434 in participants with Multiple System Atrophy,NO,Multiple System Atrophy,DRUG: ATH434 dose level 1|DRUG: ATH434 dose level 2|DRUG: Placebo,"Change in iron content as measured by brain MRI, Change from Baseline to Week 52","Change in Neurofilament Light Chain Levels, Change from Baseline to Week 52|Change in Unified MSA Rating Scale (UMSARS) Score, Change from Baseline to Week 52|Change in SF-36 Score, Change from Baseline to Week 52",,Alterity Therapeutics,,ALL,"ADULT, OLDER_ADULT",PHASE2,77,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",ATH434-201,2022-07-01,2024-11-28,2024-11-28,2021-11-05,,2024-12-13,"University of California San Diego, La Jolla, California, 92093, United States|Rush University Medical Center, Chicago, Illinois, 60612, United States|Johns Hopkins University, Baltimore, Maryland, 21287, United States|Columbia University Irving Medical Center, New York, New York, 10032, United States|The Movement Disorder Clinic of Oklahoma, Tulsa, Oklahoma, 74136, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|St Vincent's Hospital (Sydney), Darlinghurst, New South Wales, Australia|Westmead Hospital, Westmead, New South Wales, Australia|The Alfred Hospital, Melbourne, Victoria, Australia|CHU de Toulouse/Hôpital Pierre-Paul Riquet, Toulouse, Haute-Garonne, 31059, France|CHU/HU Pitié Salpêtrière, Paris, Ile-de-France, 75013, France|CHU de Bordeaux/Groupe Hospitalier Pellegrin, Bordeaux, 33076, France|CHU de Marseille/Hôpital de la Timone, Marseille, 13005, France|IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bologna, Italy|Policlinico di Milano, Milan, Italy|Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy|AOU San Giovanni di Dio Ruggi d'Aragona, Salerno, Italy|New Zealand Brain Research Institute, Christchurch, New Zealand|Auckland City Hospital, Grafton, New Zealand|University College London, London, England, United Kingdom|Newcastle University, Newcastle Upon Tyne, England, United Kingdom|Salford Royal Hospital, Salford, England, United Kingdom|Queen Elizabeth University Hospital, Glasgow, Scotland, United Kingdom",
